glp 1 drugs in development GLP-1 Agonists Weight Loss Market Report, 2025-2030 The Multi-Sector Impacts of GLP-1RA
Description
467 Under hyperglycemic conditions, GLP-1RAs regulate hypertension by inhibiting carotid body function
The announcement reinforces Altimmunes ongoing efforts to position pemvidutide within the broader GLP-1 and metabolic disease sector spanning obesity, liver disease and related cardiometabolic conditions
adult usage of weight-loss medications has more than doubled from 5.8% in early 2024 to 12.4% in 2Q/3Q 2025
doi: 10.1056/NEJMoa2032183
Steroid-induced hyperglycemia successfully treated with once-weekly dulaglutide in an old patient with type 2 diabetes
The Three-Hour Buffer: Why Bedtime Meals Are the Enemy If youre prone to late dinners or eating a meal right before bedtime, but are experiencing acid reflux, you may need to reconsider your eating schedule
